Exelixis, Inc. Stock Performance
as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
$39.93$40.83
2.04%
Downside
0.17%
Upside
52 Week's Low
52 Week's High
$31.9$49.6221.74%
Downside
21.74%
Upside
Exelixis, Inc. share price movements today
- Previous Close
- $40.80
- Open
- $40.50
- Volume
- 1.4M
- Day's Low - High
- $39.93 - $40.83
- 52 Week Low - High
- $31.9 - $49.62
Exelixis, Inc. Historical Returns
- 1 Month Return
- + 5.62 %
- 3 Month Return
- + 8.19 %
- 1 Year Return
- + 12.58 %
- 3 Year Return
- + 146.44 %
- 5 Year Return
- + 97.05 %
Exelixis, Inc. Stock Fundamentals & Key Indicators
Check Exelixis, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.9B
EPS (TTM)
2.7451
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.72%
PE Ratio (TTM)
17.15
Industry PE ratio
8.355964912280701
PEG Ratio
2.2685
EBITDA
850.0M
Revenue (TTM)
2.3B
Profit Margin
29.63%
Return On Equity TTM
30.56%
Exelixis, Inc. Stock Valuation
Track how Exelixis, Inc. P/E has moved over time to understand its valuation trends.
Exelixis, Inc. in the last 5 years
Lowest (15.15x)
September 30, 2024
Industry (8.36x)
November 8, 2025
Today (17.15x)
November 8, 2025
Highest (122.74x)
April 30, 2021
Today’s Price to Earnings Ratio: 17.15x
Exelixis, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Exelixis, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $10.9B | 97.05% | 17.15 | 29.63% | |
| BUY | $40.5B | 482.44% | -16.34 | -264.83% | |
| BUY | $58.2B | 238.64% | 1420.94 | 1.36% | |
| BUY | $105.6B | 85.89% | 29.33 | 31.35% | |
| BUY | $68.0B | 13.75% | 15.51 | 32.13% |
Stock Returns calculator for Exelixis, Inc. Stock including INR - Dollar returns
The Exelixis, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Exelixis, Inc. investment value today
Current value as on today
₹1,17,588
Returns
₹17,588
(+17.59%)
Returns from Exelixis, Inc. Stock
₹12,441 (+12.44%)
Dollar Returns*
₹5,147 (+5.15%)
Analyst Recommendation on Exelixis, Inc. Stock
Based on 26 analysts
76.92%
Buy
19.23%
Hold
3.85%
Sell
Based on 26 analysts, 76.92% of analysts recommend a 'BUY' rating for Exelixis, Inc.. Average target price of $44.42
Exelixis, Inc. Share Price Target
Get share price movements and forecasts by analysts on Exelixis, Inc..
What analysts predicted
8.24%UPSIDE
Target Price
$44.42
Current Price
$40.76
Analyzed by
26 Analysts
Target
$44.42
Exelixis, Inc. target price $44.42, a slight upside of 8.24% compared to current price of $40.76. According to 26 analysts rating.
Exelixis, Inc. Stock’s Investor Sentiment and Interest
Investment in Exelixis, Inc. Shares on INDmoney has grown by 260.86% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:260.86% versus previous 30 day period
Search interest for Exelixis, Inc. Stock has increased by 42% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:42% versus previous 30 day period
Exelixis, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Exelixis, Inc. Annual Profit & Loss
All numbers in Millions USD
Exelixis, Inc. Quarterly Cash Flow
All numbers in Millions USD
Exelixis, Inc. Annual Cash Flow
All numbers in Millions USD
Exelixis, Inc. News & Key Events
Today's Timeline - 20 October
Mon, 12:00 PM
-Exelixis announces detailed results from STELLAR-303 trial, showing zanzalintinib improves overall survival to 10.9 months versus regorafenib.
Mon, 08:18 PM
-Exelixis stock drops 12.17% after sharing detailed results from STELLAR-303 trial, despite positive overall survival findings.
Insights on Exelixis, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 5 quarters, 117.97M → 193.57M (in $), with an average increase of 11.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, EXEL stock has moved up by 5.5%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 555.44M → 597.75M (in $), with an average increase of 3.6% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 139.9%
- NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 897.2% return, outperforming this stock by 750.8%
About Exelixis, Inc.
| Organisation | Exelixis, Inc. |
| Headquarters | 1851 Harbor Bay Parkway, Alameda, CA, United States, 94502 |
| Industry | Health Technology |
| CEO | Dr. Michael M. Morrissey Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Exelixis, Inc.
Name | Title |
|---|---|
Dr. William Berg M.D. | Senior Vice President of Medical Affairs |
Mr. Patrick Joseph Haley M.B.A. | Executive Vice President of Commercial |
Dr. Stelios Papadopoulos Ph.D. | Co-Founder & Independent Chair of the Board |
Mr. Christopher J. Senner | Executive VP & CFO |
Mr. Jeffrey J. Hessekiel J.D. | Executive VP & General Counsel |
Dr. Dana T. Aftab Ph.D. | Executive Vice President of Research & Development |
Dr. Anne Champsaur M.D. | Senior Vice President of Drug Safety |
Dr. Michael M. Morrissey Ph.D. | CEO, President & Director |
Ms. Susan T. Hubbard | Executive Vice President of Public Affairs & Investor Relations |
Dr. Stefan Krauss Ph.D. | VP & Head of Business Development |
FAQs
What is Exelixis, Inc. share price today?
Exelixis, Inc. share price today is $40.76 as on at the close of the market. Exelixis, Inc. share today touched a day high of $40.83 and a low of $39.93.
What is the 52 week high and 52 week low for Exelixis, Inc. share?
Exelixis, Inc. share touched a 52 week high of $49.62 on and a 52 week low of $31.9 on . Exelixis, Inc. stock price today i.e. is closed at $40.76,which is 17.86% down from its 52 week high and 27.77% up from its 52 week low.
What is Exelixis, Inc.'s market capitalisation today?
Exelixis, Inc. market capitalisation is $0.01T as on .
How to invest in Exelixis, Inc. Stock (EXEL) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Exelixis, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Exelixis, Inc. Shares that will get you 0.0368 shares as per Exelixis, Inc. share price of $40.76 per share as on November 8, 2025 at 2:29 am IST.
What is the minimum amount required to buy Exelixis, Inc. Stock (EXEL) from India?
Indian investors can start investing in Exelixis, Inc. (EXEL) shares with as little as ₹88.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.60 in Exelixis, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Exelixis, Inc. share’s latest price of $40.76 as on November 8, 2025 at 2:29 am IST, you will get 0.2453 shares of Exelixis, Inc.. Learn more about
fractional shares .
What are the returns that Exelixis, Inc. has given to Indian investors in the last 5 years?
Exelixis, Inc. stock has given 97.05% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?